20 October, 2009 - Over 50 pharmaceutical representatives are to meet at the NGP US Summit in Florida to discuss future technology investments.
Thomas Haverty, global vice president, Global Clinical Research, Schering-Plough will be talking about Responding to 21st Century Drug Development Challenge.
25 September, 2009 - Representatives from GSK, Bayer, AstraZeneca, Novartis and Pfizer have discussed ways to combat counterfeit drug manufacturing and parallel trading at the NGP Summit.
